Yes, doctors may still perform a digital rectal exam (DRE) to check the prostate, though it’s often used alongside other tests rather than as a standalone screening tool. During a DRE, a healthcare provider inserts a gloved, lubricated finger into the rectum to feel the prostate gland for abnormalities in size, shape, texture, or tenderness. This quick, in-office procedure can help detect signs of prostate enlargement, inflammation, infection, or potential cancer.
However, the use of DRE as a routine screening method for prostate cancer has declined in recent years. Current guidelines from organizations like the U.S. Preventive Services Task Force (USPSTF) emphasize the prostate-specific antigen (PSA) blood test as the primary screening tool. The PSA test measures levels of a protein produced by the prostate; elevated levels may indicate prostate issues, including cancer. While the DRE can provide useful clinical information—especially if a patient has urinary symptoms or an abnormal PSA—it is no longer universally recommended for asymptomatic men.
That said, many urologists still include the DRE as part of a comprehensive prostate evaluation, particularly when symptoms are present or when PSA results are borderline. The exam is generally safe and causes only brief discomfort. If you’re due for a prostate check or have concerns about urinary symptoms, family history, or prostate cancer risk, talk to your doctor about which tests are right for you based on your age, health, and personal risk factors.
Ultimately, shared decision-making is key. While the finger exam may feel outdated or uncomfortable, it remains a valuable part of prostate assessment in specific clinical situations. Always discuss the benefits and limitations of any screening test with your healthcare provider to make informed choices about your health.